Related Experiment Video
Updated: Jul 6, 2026

Stem Cell Transplantation Strategies for the Restoration of Cognitive Dysfunction Caused by Cranial Radiotherapy
Published on: October 18, 2011
Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma
Ling He1,2, Daria Azizad3, Kruttika Bhat1
1Department of Radiation Oncology, David Geffen School of Medicine at UCLA.
Abstract:
Glioblastoma is the deadliest brain cancer in adults and almost all patients succumb to the tumor. While surgery followed by chemo-radiotherapy significantly delays disease progression, these treatments do not lead to long-term tumor control and targeted therapies or biologics have so far failed to further improve survival. Utilizing a transient radiation-induced state of multipotency we used the adenylcyclase activator forskolin to alter the cellular fate of glioma cells in response to radiation. The combined treatment induced the expression of neuronal markers in glioma cells, reduced proliferation and led to a distinct gene expression profile. scRNAseq revealed that the combined treatment forced glioma cells into a microglia- and neuron-like phenotypes. In vivo this treatment led to a loss of glioma stem cells and prolonged median survival in mouse models of glioblastoma. Collectively, our data suggest that revisiting a differentiation therapy with forskolin in combination with radiation could lead to clinical benefit.
Insights
This study shows that combining radiation with forskolin, a drug that activates adenyl cyclase, can reprogram deadly glioblastoma cells into less harmful types, improving survival in mice.
Area of Science:
- Neuro-oncology
- Cancer biology
- Cellular differentiation
Background:
- Glioblastoma is a fatal brain cancer with limited treatment options.
- Current therapies like surgery, chemotherapy, and radiotherapy offer only temporary disease control.
- Targeted therapies have not significantly improved glioblastoma patient survival.
Approach:
- Investigated the effect of combining radiation with forskolin, an adenyl cyclase activator, on glioma cells.
- Utilized a transient radiation-induced state of multipotency to alter cellular fate.
- Analyzed gene expression profiles and cell phenotypes using scRNAseq.
Key Points:
- Combined treatment induced neuronal markers and altered gene expression in glioma cells.
- scRNAseq revealed a shift towards microglia- and neuron-like phenotypes.
- The treatment reduced glioma stem cells and prolonged survival in mouse models.
Conclusions:
- Reprogramming glioma cells via differentiation therapy with forskolin and radiation shows promise.
- This combination strategy could potentially offer clinical benefits for glioblastoma patients.
- Further research into differentiation therapy for glioblastoma is warranted.
Related Concept Videos
The Tumor Microenvironment
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy

